(January 25, 2021, New York) — Steptoe & Johnson LLP is pleased to announce that Steve Yang has joined the firm's Intellectual Property group as a partner. Based in the New York office, Yang will focus his practice on IP litigation, as well as litigation and counseling for Chinese and Taiwanese companies.
Yang counsels clients in a wide range of technologies, including pharmaceuticals, medical devices, chemical manufacturing and compositions, and technologies in the high-tech space. He handles all facets of litigation in federal courts, as well as Section 337 investigations before the US International Trade Commission, and has served as lead counsel in inter partes reviews before the Patent Trial and Appeal Board of the US Patent and Trademark Office. Yang has also worked as an in-house counsel at a major pharmaceutical company in New Jersey, and has extensive experience with Hatch-Waxman litigations and the Hatch-Waxman statutory framework.
In welcoming Yang to the firm, Steptoe Chair Phil West said: "Steve is a bright and highly motivated rising star of the IP bar who has built significant litigation experience and shown exceptional talent in developing business at the early stage of his career. His native Chinese language and cultural affinity, combined with his chemistry background and US legal training have made Steve a sought-after IP lawyer for Chinese and Taiwanese companies seeking to enter and expand in the US market. Steve will augment our IP group's core strengths in pharmaceutical and other patent litigation, including at the Patent Office, ITC and in China, where we have a growing roster of patent litigation clients."
Steptoe's US and international Intellectual Property group enforces, protects, and develops the intellectual property rights and assets of clients in a wide range of industries. With lawyers and technology specialists in Beijing, Chicago, New York, Los Angeles, San Francisco, and Washington, the firm's patent litigation practice has been recognized by China Law & Practice, China Business Law Journal, Intellectual Asset Magazine (IAM), Chambers, and The Legal 500.
Yang commented: "Steptoe is the perfect home for my practice. The firm has a very strong presence in Asia, which will provide me with a great platform to grow and expand my practice in China and Taiwan, and it has a fantastic IP group with outstanding experience and quality, especially with pharmaceutical litigations and ITC practices. Having worked with Steptoe's attorneys in the past, I have always been impressed with their experience and skills, and I see my pharma and litigation experience being a great match with the firm's client base and growing litigation practice."
Yang earned his J.D., cum laude, from the University of New Hampshire School of Law on a full dean's merit scholarship, and his B.S. in Chemistry from the University of Wisconsin.
In more than 100 years of practice, Steptoe has earned an international reputation for vigorous representation of clients before governmental agencies, successful advocacy in litigation and arbitration, and creative and practical advice in structuring business transactions. Steptoe has more than 500 lawyers and other professional staff across offices in Beijing, Brussels, Chicago, Hong Kong, London, Los Angeles, New York, San Francisco, and Washington. For more information, visit www.steptoe.com.